Celcuity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celcuity Inc. (CELC) on December 6, 2024. The report details the effectiveness of a new shelf registration statement and the filing of a prospectus supplement to facilitate an "at-the-market" equity offering program.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity metrics. It references historical equity sales under a prior program:
- Prior Offering Proceeds: $27,817,450 in aggregate shares sold under the previous registration statement (effective November 2021).
- New Offering Capacity: Up to $125,000,000 in aggregate offering price available under the new prospectus supplement.
Material Changes
The primary material change is the transition from a prior equity offering program to a new one:
- Termination of Prior Program: The offering of shares under the Prior Registration Statement (File No. 333-261155) terminated upon the effectiveness of the new Registration Statement on December 2, 2024.
- New Registration Statement: A new Form S-3 shelf registration statement (File No. 333-281887) was declared effective by the SEC on December 2, 2024.
- Prospectus Supplement: Filed on December 6, 2024, authorizing the sale of shares with an aggregate offering price of up to $125,000,000 through Jefferies LLC as the sales agent.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond standard securities law disclaimers. The document explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy common stock in any state where such offer would be unlawful.
Key Facts for Investor Verification
- Verify the current share count and potential dilution impact of the new $125,000,000 offering capacity.
- Confirm the status of the prior $27.8 million offering and whether any shares remain unsold under the terminated program.
- Review the full Prospectus Supplement (Exhibit 424(b)) for specific terms, commissions, and use of proceeds.
- Check recent stock price trends to assess the likelihood and timing of sales under the new at-the-market agreement.